309 related articles for article (PubMed ID: 18625427)
1. Novel hepatitis C drugs in current trials.
Kronenberger B; Welsch C; Forestier N; Zeuzem S
Clin Liver Dis; 2008 Aug; 12(3):529-55, viii. PubMed ID: 18625427
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C virus virology and new treatment targets.
Meier V; Ramadori G
Expert Rev Anti Infect Ther; 2009 Apr; 7(3):329-50. PubMed ID: 19344246
[TBL] [Abstract][Full Text] [Related]
3. Oligonucleotide-based therapeutic options against hepatitis C virus infection.
Trepanier JB; Tanner JE; Alfieri C
Antivir Ther; 2006; 11(3):273-87. PubMed ID: 16759043
[TBL] [Abstract][Full Text] [Related]
4. [Current Guidelines for treatment of hepatitis C. The eradication of HCV as a goal].
Sarrazin C; Zeuzem S
Pharm Unserer Zeit; 2011 Jan; 40(1):52-9. PubMed ID: 21194083
[No Abstract] [Full Text] [Related]
5. Evaluation systems for anti-HCV drugs.
Moriishi K; Matsuura Y
Adv Drug Deliv Rev; 2007 Oct; 59(12):1213-21. PubMed ID: 17720275
[TBL] [Abstract][Full Text] [Related]
6. The hepatitis C virus life cycle as a target for new antiviral therapies.
Pawlotsky JM; Chevaliez S; McHutchison JG
Gastroenterology; 2007 May; 132(5):1979-98. PubMed ID: 17484890
[TBL] [Abstract][Full Text] [Related]
7. Challenges and successes in developing new therapies for hepatitis C.
De Francesco R; Migliaccio G
Nature; 2005 Aug; 436(7053):953-60. PubMed ID: 16107835
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C: changing genotype distribution with important implications for patient management.
van Soest H; Boland GJ; van Erpecum KJ
Neth J Med; 2006 Apr; 64(4):96-9. PubMed ID: 16609154
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus: prospects for future therapies.
Wilkinson T
Curr Opin Investig Drugs; 2001 Nov; 2(11):1516-22. PubMed ID: 11763151
[TBL] [Abstract][Full Text] [Related]
10. Recent advances in the discovery of small molecule therapies for HCV.
Myles DC
Curr Opin Drug Discov Devel; 2001 Jul; 4(4):411-6. PubMed ID: 11727306
[TBL] [Abstract][Full Text] [Related]
11. 3-Amino-2(5H)furanones as inhibitors of subgenomic hepatitis C virus RNA replication.
Iannazzo D; Piperno A; Romeo G; Romeo R; Chiacchio U; Rescifina A; Balestrieri E; Macchi B; Mastino A; Cortese R
Bioorg Med Chem; 2008 Nov; 16(21):9610-5. PubMed ID: 18835180
[TBL] [Abstract][Full Text] [Related]
12. Tailored treatment for hepatitis C.
Berg T
Clin Liver Dis; 2008 Aug; 12(3):507-28, vii-viii. PubMed ID: 18625426
[TBL] [Abstract][Full Text] [Related]
13. HCV research and anti-HCV drug discovery: toward the next generation.
Wakita T
Adv Drug Deliv Rev; 2007 Oct; 59(12):1196-9. PubMed ID: 17905463
[TBL] [Abstract][Full Text] [Related]
14. Progress and development of small molecule HCV antivirals.
Ni ZJ; Wagman AS
Curr Opin Drug Discov Devel; 2004 Jul; 7(4):446-59. PubMed ID: 15338954
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of HCV p7 as a therapeutic target.
Griffin S
Curr Opin Investig Drugs; 2010 Feb; 11(2):175-81. PubMed ID: 20112167
[TBL] [Abstract][Full Text] [Related]
16. New kinetic models for the hepatitis C virus.
Perelson AS; Herrmann E; Micol F; Zeuzem S
Hepatology; 2005 Oct; 42(4):749-54. PubMed ID: 16175615
[TBL] [Abstract][Full Text] [Related]
17. The management of hepatitis C.
Pan JJ; Firpi RJ
Minerva Gastroenterol Dietol; 2009 Mar; 55(1):23-35. PubMed ID: 19212305
[TBL] [Abstract][Full Text] [Related]
18. Treatment predictors of a sustained virologic response in hepatitis B and C.
Kau A; Vermehren J; Sarrazin C
J Hepatol; 2008 Oct; 49(4):634-51. PubMed ID: 18715665
[TBL] [Abstract][Full Text] [Related]
19. Current therapy of hepatitis C.
de Knegt RJ
Scand J Gastroenterol Suppl; 2006; (243):65-9. PubMed ID: 16782624
[TBL] [Abstract][Full Text] [Related]
20. High-throughput screening of HCV RNA replication inhibitors by means of a reporter replicon system.
Hao W; Duggal R
Methods Mol Biol; 2009; 510():243-50. PubMed ID: 19009266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]